Capisol SL 250mg/175mg Injection
Marketer
Orsis Pharmaceuticals
Salt Composition
Ceftriaxone (250mg) + Sulbactam (175mg)
Overview Capisol SL 250mg/175mg Injection
Combiflox 250mg/175mg Injection is a dual-action antibiotic indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, thereby curbing infection spread. Administration of Combiflox 250mg/175mg Injection must be under strict medical supervision. Consistent adherence to the prescribed dosage schedule is crucial; completing the entire course, even with symptom improvement, is vital. Premature cessation may compromise treatment efficacy. Commonly reported adverse effects include nausea, vomiting, diarrhea, and dyspepsia. Any worsening of side effects warrants immediate consultation with your physician. Allergic reactions (e.g., skin rashes, pruritus, edema, respiratory distress) require prompt medical attention. Prior to commencing treatment, inform your doctor of all current medications and pre-existing conditions. This is especially important for pregnant or lactating individuals. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, refrain from operating vehicles if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and sufficient hydration will aid recovery. Your doctor may order routine laboratory and imaging tests to monitor treatment response.
Uses of Capisol SL 250mg/175mg Injection
Infections caused by bacteria
Major Benefits of Capisol SL 250mg/175mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Capisol SL 250mg/175mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Capisol SL 250mg/175mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Capisol SL 250mg/175mg Injection works:
Ceftriaxone and Sulbactam, combined as Capisol SL 250mg/175mg Injection, offer a dual-action antibacterial approach. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering bacterial survival. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Capisol SL 250mg/175mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Capisol SL 250mg/175mg is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no harmful consequences for the fetus; nevertheless, clinical data from human subjects are scarce.
Breast feedingCAUTION
Administering Capisol SL 250mg/175mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Capisol SL 250mg/175mg Injection might reduce vigilance, impair vision, and induce drowsiness or dizziness. Refrain from driving if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Capisol SL 250mg/175mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Capisol SL 250mg/175mg Injection cautiously, potentially requiring dosage modification. Mild to moderate liver dysfunction does not necessitate dosage alteration of Capisol SL 250mg/175mg Injection. Physician consultation is advised.
What if you forget to take Capisol SL 250mg/175mg Injection :
Should you forget a scheduled dose of Capisol SL 250mg/175mg Injection, seek medical advice.
Facts to Know About Capisol SL 250mg/175mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently